Search

THE VALUE OF SECOND OPINIONS ON THYROID NODULE MANAGEMENT PROVIDED VIA DIRECT-TO-CONSUMER TELEMEDICINE SERVICE

Endocrine Surgery

Samuel Dudley, MD; Marion B Gillespie, MD

University of Tennessee Health Science Center

IMPACT OF HOSPITAL SAFETY NET BURDEN ON THYROID CANCER SURVIVAL

Endocrine Surgery

Megh Shah, BA; Ryan Jin, BA; Christopher C Tseng, BS; Rushi Patel, BA; Dylan F Roden, MD; Richard C Park, MD

Rutgers New Jersey Medical School

CAN AFIRMA® EXPRESSION ATLAS PROGNOSTICATE SUSPICIOUS AND MALIGNANT THYROID NODULES NODULES?

Endocrine Surgery

Will Thedinger, BA; Jagdish Dhingra, MD

Tufts Medical Center

UPDATE ON SAFETY AND OUTCOMES OF 300 CONSECUTIVE TRANSORAL THYROIDECTOMY CASES

Endocrine Surgery

Danielle R Trakimas, MD, MSE; Christopher Razavi, MD; Khalid Ali, MD; Lena Chen, BS; Ralph P Tufano, MD; Jonathon O Russell, MD

Johns Hopkins Hospital

OPIOID PRESCRIBING IN PATIENTS UNDERGOING NECK DISSECTION FOR THYROID MALIGNANCY

Endocrine Surgery

Jennifer March; James Lim; Maisie Shindo

Oregon Health and Science University

PATIENT COMPLIANCE WITH SURVEILLANCE OF THYROID NODULES CLASSIFIED AS ATYPIA OF UNDETERMINED SIGNIFICANCE

Endocrine Surgery

Benjamin K Walters, MD; Travis R Newberry, MD; Alex J Mckinlay, MD

San Antonio Military Medical Center